Cited by 45Parkinson's Disease Mechanisms and TreatmentsHealth Systems, Economic Evaluations, Quality of LifeNeurological disorders and treatments

Prospective study on cost-effectiveness of home-based motor assessment in Parkinson’s disease

Cubo, E, Mariscal, N, Solano, B, Becerra, V, Armesto, D, Calvo, S, Arribas, J, Seco, J +3 more·2017·Journal of Telemedicine and Telecare

Abstract

Introduction: Treatment adjustments in Parkinson’s disease (PD) are in part dependent on motor assessments. The aim of this study was to evaluate the cost-effectiveness of home-based motor monitoring plus standard in-office visits versus in-office visits alone in patients with advanced PD. Methods: The procedures consisted of a prospective, one-year follow-up, randomized, case-control study. A total of 40 patients with advanced PD were randomized into two groups: 20 patients underwent home-based motor monitoring by using wireless motion sensor technology, while the other 20 patients had in-office visits. Motor and non-motor symptom severities, quality of life, neuropsychiatric symptoms, and comorbidities were assessed every four months. Direct costs were assessed using a standardized questionnaire. Cost-effectiveness was assessed using the incremental cost-effectiveness ratio (ICER). Results: Both groups of PD patients were largely comparable in their clinical and demographic variables at baseline; however, there were more participants using levodopa-carbidopa intestinal gel in the home-based motor monitoring group. There was a trend for lower Unified Parkinson’s Disease Rating Scale functional status (UPDRS II) scores in the patients monitored at home compared to the standard clinical follow-up ( p = 0.06). However, UPDRS parts I, III, IV and quality-adjusted life-years scores were similar between both groups. Home-based motor monitoring was cost-effective in terms of improvement of functional status, motor severity, and motor complications (UPDRS II, III; IV subscales), with an ICER/UPDRS ranging from €126.72 to €701.31, respectively. Discussion: Home-based motor monitoring is a tool which collects cost-effective clinical information and helps augment health care for patients with advanced PD.

Integrity signals

Registry

Crossref · 10.1177/1357633x16638971

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cubo et al. reported a trend of lower PD functional status (UPDRS I) in patients on home-based monitoring compared to patients in standard in-office visits (P = 0.06).

    “In Spain, Cubo et al. [34] reported a trend of lower PD functional status (the Unified Parkinson’s Disease Rating Scale, UPDRS I) in patients on home-based monitoring compared to patients in standard in-office visits (P = 0.06), while other outcomes (measured by UPDRS II, III, IV subscales) and HRQoL in PD did not show statistically significant differences between the intervention and control”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Cubo, E., Mariscal, N., Solano, B., Becerra, V, Armesto, D., Calvo, S., Arribas, J., Seco, J., Martinez, A., Zorrilla, L., & Heldman, D.
Affiliations
  • Hospital Universitario de Burgos (ES)
  • Centro Servicios Avanzados, Burgos, Spain
  • Great Lakes NeuroTechnologies (United States) (US)
Corresponding author
Cubo, E
Venue
Journal of Telemedicine and Telecare
Published
2016-07-08
Volume
23
Issue
2
Pages
328-338
ISSN
  • 1357-633X (ISSN-L)
  • 1758-1109
OpenAlex
W2310365250
Cited by
45
References
33
Citations by year
2026: 2 · 2025: 5 · 2024: 2 · 2023: 5 · 2022: 7 · 2021: 6 · 2020: 7 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 1
FWCI
2.76
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Telemedicine and Telecare (publishedVersion)
  • PubMed (publishedVersion)
Funders
Allergan
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Neurology › Neurological disorders and treatments
Keywords
Parkinson's disease, cost-effectiveness, advanced Parkinson's disease, motor complications, remote patient monitoring, quality-adjusted life years
MeSH terms
Aged, Cost-Benefit Analysis, Female, Humans, Male, Monitoring, Physiologic, Parkinson Disease, Prospective Studies, Case-Control Studies, Telemedicine, Monitoring, Ambulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review